In preclinical trials utilizing a mouse model of PCa xenografts, inhibition of the CXCL12-CXCR4 axis demonstrated anti-angiogenic effects, evidenced by a reduction in both the number and density of blood vessels [36]. The gene discussed is CXCL12; the disease is posterior cortical atrophy.